is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the U.S. Food and Drug Administration...
Shares of Moderna are trading 2% lower Thursday morning as the company announced it had agreed to amend the delivery schedule of additional COVID-19...
Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th announced that the U.S. Food...
Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster...
Shares of Valneva plunged 20% on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European Commission was being scrapped and...